Vital Farms, Inc.
For the period ended Mar 29, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 29, 2026 · Filed May 7, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Other Information
Item 5. Other Information
Director and Officer Trading Arrangements
During the 13-week period ended March 29, 2026, certain of our directors or officers (as defined in Rule 16a-1(f) under the Exchange Act)adopted orterminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K, as set forth in the table below:
| Type of Trading Arrangement | |||||
|---|---|---|---|---|---|
| Name and Position · Action · Adoption/ Termination Date · Rule 10b5-1* · Non-Rule 10b5-1** · Total Shares of Common Stock to be Sold · Total Shares of Common Stock to be Purchased · ExpirationDate | |||||
| Thilo Wrede, Chief Financial Officer | Adoption | March 2, 2026 | X | 14,595(1) | December 31, 2026 |
| Joanne Bal, Chief Legal Officer, Corporate Secretary and Head of Impact | Adoption | March 2, 2026 | X | 12,253(2) | December 31, 2026 |
- Contract, instructions, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
** “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act.
(1)
Includes up to 2,500 shares subject to vested stock options previously granted to Mr. Wrede. The actual number of shares underlying such stock options that will be sold under the Rule 10b5-1 trading arrangement will be net of the number of shares sufficient to cover the costs associated with the exercise of such shares and is not determinable at this time.
(2)
Includes up to 12,253 shares subject to vested stock options previously granted to Ms. Bal. The actual number of shares underlying such stock options that will be sold under the Rule 10b5-1 trading arrangement will be net of the number of shares sufficient to cover the costs associated with the exercise of such shares and is not determinable at this time.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.